Tonix Pharmaceuticals Holding Corp. (TNXP)
13.98
-0.15
(-1.06%)
USD |
NASDAQ |
Apr 17, 16:00
13.98
0.00 (0.00%)
Pre-Market: 20:00
Tonix Pharmaceuticals Research and Development Expense (Quarterly) : 16.94M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | 1.477M |
| Jaguar Health, Inc. | 14.31M |
| MetaVia, Inc. | 0.241M |
| Seastar Medical Holding Corp. | 2.20M |
| Jupiter Neurosciences, Inc. | 0.0437M |